Physician profile

Anthony Tyler Manning

Surgery · Conway, AR

NPI 1811333206

$24,280.42

in general payments reported to CMS, 2019-2025

44 companies · $675 in 2025

The $675 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).

See the full distribution for Surgery

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,266.71
Gift$16.25

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Intuitive Surgical, INC. $19,856.73 2021-2025 Da Vinci Surgical System
Medtronic USA, INC. $959.65 2019-2020
Medical Device Business Services, INC. $819.33 2019
Ethicon US, LLC $447.70 2019-2025 Echelon; Endopath
Tela Bio, INC. $284.79 2023-2025 Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex)
Enterra Medical, INC. $264.49 2023-2025
Medtronic, INC. $191.84 2025 Signia, Ligasure
Smith+Nephew, INC. $154.67 2019-2025 Pico 7, Grafix Pl, Stravix
Baudax Bio INC. $150.04 2020-2021
Kci USA, INC. $121.59 2020-2023 V.A.C. Veraflo Cleanse Choice, Prevena
Novo Nordisk INC $96.99 2021-2024 Wegovy
Polynovo North America LLC $71.61 2023-2024 Novosorb Btm
Davol INC. $62.31 2020-2022
Hologic Sales and Service, LLC $61.76 2023-2024 Localizer, Magseed, Trunode
Vertex Pharmaceuticals Incorporated $56.85 2025
Show all 44 companies
CompanyGeneral paymentsYearsTop products
Acera Surgical, INC. $50.07 2019-2021
Abbvie INC. $43.37 2024
Kowa Pharmaceuticals America, INC. $42.68 2023 Seglentis
Baxter Healthcare $41.08 2020
Tas Medical, INC. $38.92 2024
Takeda Pharmaceuticals U.S.A., INC. $36.92 2023-2024 Gattex
Silk Road Medical, INC. $33.54 2020-2021
Solventum Corporation $31.57 2024-2025 V.A.C. Veraflo Cleanse Choice, Prevena, V.A.C.Ulta
Hologic INC $30.81 2022
Integra Lifesciences Corporation $27.58 2022
Avinger INC. $22.54 2019
Pacira Pharmaceuticals Incorporated $22.06 2025 Exparel
Allergan, INC. $20.83 2021
Heron Therapeutics, INC. $20.44 2023 Zynrelef
Misonix INC $19.11 2020
W. L. Gore & Associates, INC. $18.77 2025 Gore Enform Preperitoneal Biomaterial
Innocoll Pharmaceuticals Limited $16.56 2022
Shield Therapeutics INC $16.42 2023 Accrufer
Z-Medica, LLC $16.26 2019
Organogenesis INC. $15.12 2021
Microline Surgical INC $14.36 2025
Boston Scientific Corporation $13.63 2024 Varithena Administration Pack
Ambu INC. $13.60 2023
Lemaitre Vascular, INC. $13.21 2019
Teleflex LLC $13.02 2021
Endo Pharmaceuticals INC. $12.39 2022
Merck Sharp & Dohme LLC $12.37 2019
Medtronic Vascular, INC. $11.56 2019
Becton, Dickinson and Company $11.28 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Anthony Tyler Manning

$24,280.42

in general payments reported 2019-2025

Years
2019-2025
Top company
Intuitive Surgical, INC.
Context
The $675 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).

https://glasscript.com/doctor/870192/anthony-tyler-manning

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.